tiprankstipranks
COSMOS Pharmaceutical Corporation (JP:3349)
:3349
Japanese Market

COSMOS Pharmaceutical Corporation (3349) Income Statement

Compare
0 Followers

COSMOS Pharmaceutical Corporation Income Statement

Last quarter (Q4 2023), COSMOS Pharmaceutical Corporation's total revenue was ¥249.68B, an increase of 12.77% from the same quarter last year. In Q4, COSMOS Pharmaceutical Corporation's net income was ¥7.10B. See COSMOS Pharmaceutical Corporation’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
¥ 964.99B¥ 827.70B¥ 755.41B¥ 726.42B¥ 684.40B
Gross Profit
¥ 188.31B¥ 168.72B¥ 151.45B¥ 145.11B¥ 134.98B
Operating Expenses
¥ 156.81B¥ 138.59B¥ 121.65B¥ 111.96B¥ 105.89B
Depreciation and Amortization
¥ 19.92B¥ 17.37B¥ 15.11B¥ 13.79B¥ 13.56B
EBITDA
¥ 53.74B¥ 47.50B¥ 44.91B¥ 46.93B¥ 42.66B
Operating Income
¥ 31.50B¥ 30.13B¥ 29.80B¥ 33.15B¥ 29.09B
Other Income/Expenses
¥ 2.22B¥ 2.65B¥ 3.25B¥ 5.45B¥ 1.31B
Pretax Income
¥ 33.72B¥ 32.77B¥ 33.05B¥ 38.60B¥ 30.40B
Net Income
¥ 24.45B¥ 23.80B¥ 23.16B¥ 27.16B¥ 21.43B
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ 308.61¥ 300.48¥ 292.37¥ 342.89¥ 270.65
Diluted EPS
¥ 308.61¥ 300.48¥ 292.37¥ 342.89¥ 270.65
Weighted Average Shares Outstanding
79.24M 79.20M 79.20M 79.20M 79.20M
Weighted Average Shares Outstanding (Diluted)
79.24M 79.20M 79.20M 79.20M 79.20M
Currency in JPY

COSMOS Pharmaceutical Corporation Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis